Zobrazeno 1 - 10
of 157
pro vyhledávání: '"N V, Medvedeva"'
Autor:
N. V. Medvedeva, N. A. Maslyuk
Publikováno v:
Управленческое консультирование, Vol 0, Iss 10, Pp 80-97 (2023)
This article discusses the practice of interaction between public authorities of the subjects of the Russian Federation and municipalities in the process of creating a favorable investment climate in the implementation of the regional investment stan
Externí odkaz:
https://doaj.org/article/296388ceb2ba4cc39cc5a02a193585a5
Autor:
A. A. Maschan, A. G. Rumyantsev, L. G. Kovaleva, B. V. Afanasiev, T. I. Pospelova, A. Yu. Zaritskiy, K. M. Abdulkadyrov, V. V. Ptushkin, N. V. Tsvetaeva, I. A. Lisukov, G. N. Salogub, A. K. Golenkov, N. V. Medvedeva, O. A. Rukavitsyn, V. L. Ivanova, I. V. Markova
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 36-45 (2022)
New guidelines on diagnosis and treatment of a primary immune thrombocytopenia (ITP) in children and adults, on the basis of modern pathogenesis conceptions and considering possibilities of hematological practice in Russia are presented. Guidelines a
Externí odkaz:
https://doaj.org/article/6220b641931849d780f5e030ba86106b
Autor:
S. S. Bessmeltsev, E. V. Karyagina, L. V Stelmashenko, N. V. Stepanova, E. R. Machulaiten, G. N. Salogub, I. A. Skorokhod, N. V. Medvedeva, E. I. Podoltseva, L. M. Matyukhina, A. S. Nizamutdinova, K. M. Abdulkadyrov
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 52-62 (2022)
The characteristics of peripheral neuropathy (PN), its incidence and a possibility of relieving in multiple myeloma (MM) patients receiving bortezomib are presented. A hundred and twenty-four patients with recurrent/refractory MM and 14 primary patie
Externí odkaz:
https://doaj.org/article/d13b8f52d7bd41c4a2309ca155e24f5c
Autor:
S. S. Bessmeltsev, L. V. Stelmashenko, E. V. Kariagina, N. V. Stepanova, G. N. Salogub, T. L. Shelkovskaya, T. A. Malakhova, I. A. Skorokhod, E. I. Podoltseva, N. O. Saraeva, O. I. Kovalev, A. V. Klimovich, N. V. Medvedeva, K. M. Abdulkadyrov, L. I. Krylova, T. H. Potrachkova, M. A. Novikova, E. R. Machulaitene, E. I. Darskaya, L. M. Matukhina, N. A. Kotova, O. Ya. Kostina, I. A. Novokreshchenova
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 6-13 (2022)
We used the bortezomib plus dexamethasone (VD) and bortezomib plus MP (VMP) in 56 previously untreated elderly patients with multiple myeloma. The patients were 65–89 years old. For patients who received bortezomib plus MP the overall response rate
Externí odkaz:
https://doaj.org/article/c2efdc3ba2154cfb809d445aa9adf43d
Autor:
A. M. Chekalov, M. O. Popova, I. V. Tsygankov, Yu. A. Rogacheva, N. P. Volkov, K. V. Lepik, M. V. Demchenkova, T. V. Schneider, Yu. V. Kopeikina, N. V. Medvedeva, I. S. Zyuzgin, E. S. Pavlyuchenko, A. N. Levanov, A. A. Myasnikov, E. V. Kariagina, N. B. Mikhailova, V. V. Baykov, A. D. Kulagin
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 29, Iss 3, Pp 65-73 (2022)
Introduction. The risk of developing Hodgkin lymphoma (HL) with HIV infection is higher than in the general population, and the course of the disease itself is more aggressive. Currently, there is no unified approach to the treatment of HIV-related H
Externí odkaz:
https://doaj.org/article/ea9ed8309c9d4e90a602283379e9c436
Autor:
V. G. Potapenko, M. M. Antonov, N. V. Vinogradova, E. V. Doguzhieva, V. E. Karev, E. S. Karamurzin, G. V. Kachenya, A. V. Klimovich, S. S. Kozlov, Yu. A. Krivolapov, S. V. Lapin, M. Yu. Pervakova, N. A. Potikhonova, I. P. Fedunyak, N. V. Medvedeva
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 89-97 (2022)
Secondary hemophagocytic syndrome (sHLH) is a hyperinflammatory reaction which manifests with fever, cytopenia and organ damage. possible causes of sHLH include leishmaniasis. The article describes a clinical case of sHLH in patient with visceral lei
Externí odkaz:
https://doaj.org/article/89a62f4056fd442aab9f1a4688fce105
Autor:
V. G. Potapenko, E. V. Baumert, A. A. Bobrova, R. V. Vashchenkov, N. V. Dorofeeva, K. D. Kaplanov, E. V. Karyagina, A. N. Levanov, A. S. Luchinin, S. I. Moiseev, A. V. Novitskii, A. S. Nizamutdinova, О. V. Pirogova, S. A. Povzun, М. V. Platonov, V. V. Porunova, D. А. Ptashnikov, V. V. Ryabchikova, S. Ya. Simeniv, I. А. Skorokhod, Е. А. Ukrainchenko, D. А. Chaginskaya, T. V. Shelekhova, M. N. Shirokova, A. A. Shutylev, N. V. Medvedeva
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 48-61 (2022)
Background. The treatment options for patients with multiple myeloma who refractory to previous bortezomib and lenalidomide therapy are limited. Pomalidomide is ап immunomodulatory agent that was registered for the treatment of patients with double
Externí odkaz:
https://doaj.org/article/df93b644f61c43f1a2b7b163a8dd215b
Publikováno v:
Obrazovanie i Nauka, Vol 22, Iss 1, Pp 9-30 (2020)
Introduction. Successful solution of the tasks of socio-economic development in the modern world is possible only in the case of effective functioning of the education system, which would provide training for a competitive personality, focused on con
Externí odkaz:
https://doaj.org/article/5378ea85785d4f048812c6dd6fdc9616
Publikováno v:
Informatics and education. 37:53-61
The COVID-19 pandemic has accelerated the process of digitalization of school education, the transfer of some classes to the virtual space. However, the ambiguity of the perception of the changes taking place, the high level of discussion in assessin
Autor:
I. A. Samorodova, S. N. Bondarenko, V. N. Ovechkina, A. V. Klimovich, E. I. Podolceva, N. V. Medvedeva, A. S. Nizamutdinova, E. V. Karyagina, B. I. Smirnov, I. S. Moiseev, L. S. Zubarovskaya, B. V. Afanasyev
Publikováno v:
Онкогематология, Vol 13, Iss 1, Pp 8-20 (2018)
Introduction. The question of the most adequate treatment strategy of AML in cases when it is impossible to perform allogeneic HSCT because of any reason still remains open.The aim of this study was to assess the long-term survival of patients with A
Externí odkaz:
https://doaj.org/article/e9677f13eb234f46bc06ba86a1ead79c